Martek revenues up three percent as non-infant food booms
Its omega-3 non-infant formula foods and beverages division turned in impressive growth of 60 per cent quarter-on-quarter from $2.62m to $4.2m.
Its core infant formula business registered only four percent growth – from $71.5m to $74.6m – a factor that contributed to the $200m purchase of supplements company, Amerifit last month.
Its pregnancy, nursing, nutritional supplements and animal feeds business grew 30 percent from $5.67m to $7.38m.
“Beyond 2010, the Amerifit platform should enable Martek to develop consumer brands for some of the exciting new products in our research and development pipeline, resulting in an acceleration of products to the marketplace and increased gross profit opportunities as we move up the value chain by getting closer to the consumer," said chief executive officer, Steve Dubin.
